During the past decade, School of Medicine and Pharmacology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "School of Medicine and Pharmacology" are "Type 2 Diabetes" (2 trials). Many other conditions were trialed in "School of Medicine and Pharmacology" in a lesser frequency.

Most popular intervention types in "School of Medicine and Pharmacology" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "DIO-902" (2 trials) and "DIO-902 placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "School of Medicine and Pharmacology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "School of Medicine and Pharmacology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in School of Medicine and Pharmacology, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in School of Medicine and Pharmacology, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".